vimarsana.com

Latest Breaking News On - China national medical products association - Page 1 : vimarsana.com

Cytek Biosciences Reports First Quarter 2024 Financial Results

Cytek Biosciences Reports First Quarter 2024 Financial Results
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Iruplinalkib Improves PFS Vs Crizotinib in Locally Advanced or Metastatic ALK+ NSCLC

Treatment with iruplinalkib significantly improved progression-free survival and produced a higher objective response rate compared with crizotinib in patients with ALK TKI–naïve, locally advanced and metastatic ALK-positive non–small cell lung cancer, according to data from a prespecified interim analysis of the phase 3 INSPIRE trial.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.